Li-Chia Chen

Li-Chia Chen is a Professor at the University of Manchester, affiliated with the Division of Pharmacy and Optometry and the Centre for Pharmacoepidemiology and Drug Safety. With over two decades of academic and professional experience, she bridges clinical pharmacy with population health research, focusing on optimizing medication use and improving healthcare systems.

• PhD in Clinical and Cost-Effectiveness of COX-2 Inhibitors (University of Manchester, 2005)
• MSc in Drug Utilisation Evaluation (National Cheng Kung University, 1996)
• BSc in Pharmacy (Kaohsiung Medical University, 1993)

Her research integrates pharmacoepidemiology, health economics, and drug safety to address critical issues in patient-centred healthcare. She specializes in secondary database analysis (e.g., Taiwan National Health Insurance Database, UK CPRD) and mixed-methods approaches for policy evaluation.

Recent publications highlight trends in opioid utilization, breast cancer therapeutic adherence, and cross-national healthcare comparisons. Her work contributes to SDGs related to health (3, 17) and education (4).

• Active participant in global opioid utilization research
• Developed decision-support tools for cancer symptom management
• Advocates for pharmacy service innovation and safety indicators